Trevena Inc (NASDAQ:TRVN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TRVN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TRVN

  • Market Cap$397.230m
  • SymbolNASDAQ:TRVN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS89532E1091

Company Profile

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

Latest TRVN news

Currently there for this company. Visit our news hub for other news .